Tag:

biotechnology company

Latest Headlines

Latest Headlines

Merck site to reopen as biotech breeding ground

What do you do with an old research site? You make it into a new one. Merck ($MRK) has donated its research facility at Newhouse, Scotland, including equipment and a library of 100,000 compounds, to

UK's biotech stars may be fading, but new hopefuls shine

The Guardian sings a dirge for the biotech dead as it counts the victims among the small-cap developers in recent times. It's a familiar obituary: Antisoma, now a brain-dead shell company, Renovo,

R&D trends spur CRO business

Since 2004, Richard Lin has watched as his fledgling contract research business grew to 17 full-timers occupying 33,000 square feet of office and lab space at three San Diego-area locations. The

C&L: Una Ryan leaves Avant

Avant Immunotherapeutics today announced the departure of Una Ryan, Ph.D, President and CEO, effective immediately. Watson Pharmaceuticals announced that co-founder and Chairman Allen Chao has

ALSO NOTED: BMS: Buyer or buyout target?; LAB Research readies big expansion;Malaysia readies biotech investments; and much mor

> Market-watchers love to speculate. Their latest topic? Bristol-Myers Squibb, which has been paring away its "non-core" businesses over the last few months.

Neurogen cuts 70 jobs in restructuring

Neurogen is slashing 70 jobs in a restructuring that will focus company assets around its clinical programs. The drug developer is focused on insomnia, Parkinson's disease, restless legs syndrome and

C&L: Valeant makes management changes

Valeant Pharmaceuticals International has appointed J. Michael Pearson to the position of chief executive officer following the resignation of Timothy Tyson as president, chief executive officer and

Press Release: Nuon Therapeutics Completes Agreement on Tranilast With Kissei Pharmaceutical

Nuon Therapeutics Completes Licensing, Supply and Collaboration Agreement on Tranilast With Kissei Pharmaceutical Nuon Therapeutics, Inc., a clinical stage biotechnology company, today announced the

Press Release: Osprey Pharmaceuticals Limited Secures $9 Million In Financing

Press Release: Osprey Pharmaceuticals Limited Secures $9 Million In Financing

Press Release: Shire Pharmaceuticals Group Licenses The North American Rights For SPD754

Press Release: Shire Pharmaceuticals Group Licenses The North American Rights For SPD754